Perry David P's Form 4 filing
Better Therapeutics, Inc. (BTTX) · filed Apr 12, 2023
- Accession no.
- 0000899243-23-011231
- Filed
- Apr 12, 2023, 9:44 PM ET
- Trade date
- Apr 10, 2023
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market purchases total $4.10M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Perry David PCIK 0001105941 | Director, Officer (See Remarks), 10% Owner |
| David P. Perry 2015 TrustCIK 0001890678 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 10, 2023 | Common Stock | PPurchaseAcquired | +1,333,333 | $0.825 | +$1,099,999.73 | 11,797,348 | Indirect | |
| Apr 10, 2023 | Common Stock | PPurchaseAcquired | +3,636,364 | $0.825 | +$3,000,000.3 | 3,636,364 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.